|
WO2007023389A2
|
|
Polymorphic forms of 3-amino-1-propanesulfonic acid
|
|
TW200716088A
|
|
Formulations and methods for treating amyloidosis
|
|
AU2006201445A1
|
|
Compounds and methods for modulating cerebral amyloid angiopathy
|
|
CA2592320A1
|
|
Methods and compositions for treating amyloid-related diseases
|
|
CA2586111A1
|
|
Methods and fluorinated compositions for treating amyloid-related diseases
|
|
WO2006008661A2
|
|
Diagnostic methods of multiple organ amyloidosis
|
|
EP1841460A2
|
|
Therapeutic formulations for the treatment of beta-amyloid related diseases
|
|
AU2005201745A1
|
|
Stereoselective antifibrillogenic peptides and peptidomimetics thereof
|
|
CA2504471A1
|
|
Pharmaceutical formulations of amyloid inhibiting compounds
|
|
TW200517367A
|
|
Improved pharmaceutical drug candidates and methods for preparation thereof
|
|
EP1658264A2
|
|
Methods and compositions for treating amyloid-related diseases
|
|
EP1646375A2
|
|
Treatment of protein aggregation disorders
|
|
US7414076B2
|
|
Methods and compositions for treating amyloid-related diseases
|
|
US2005143462A1
|
|
Pharmaceutical drug candidates and methods for preparation thereof
|
|
US2005038117A1
|
|
Methods and compositions for treating amyloid-related diseases
|
|
US2005142191A1
|
|
Pharmaceutical formulations of amyloid inhibiting compounds
|
|
AU2004202703A1
|
|
Methods and compositions to treat glycosaminoglycan-associated molecular interactions
|
|
US2007135337A2
|
|
Vaccine for the Prevention and Treatment of Alzheimer's and Amyloid Related Diseases
|
|
WO2005079780A1
|
|
Amidine derivatives for treating amyloidosis
|
|
US2005182118A1
|
|
Amidine derivatives for treating amyloidosis
|
